vs
Amplitude, Inc.（AMPL）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Amplitude, Inc.的1.8倍（$168.4M vs $91.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 17.0%），过去两年Amplitude, Inc.的营收复合增速更高（12.2% vs 10.6%）
Amplitude是一家美国企业，专注于研发数字分析软件，能够帮助企业梳理用户行为数据、优化产品决策与数字化运营体验。该公司于2021年9月28日在纳斯达克交易所挂牌上市，股票代码为AMPL。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
AMPL vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.8倍
$91.4M
营收增速更快
ESPR
高出126.7%
17.0%
两年增速更快
AMPL
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.4M | $168.4M |
| 净利润 | $-17.7M | — |
| 毛利率 | 74.6% | — |
| 营业利润率 | -18.3% | 50.6% |
| 净利率 | -19.3% | — |
| 营收同比 | 17.0% | 143.7% |
| 净利润同比 | 45.8% | — |
| 每股收益（稀释后） | $-0.13 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPLESPR
| Q4 25 | $91.4M | $168.4M | ||
| Q3 25 | $88.6M | $87.3M | ||
| Q2 25 | $83.3M | $82.4M | ||
| Q1 25 | $80.0M | $65.0M | ||
| Q4 24 | $78.1M | $69.1M | ||
| Q3 24 | $75.2M | $51.6M | ||
| Q2 24 | $73.3M | $73.8M | ||
| Q1 24 | $72.6M | $137.7M |
净利润AMPLESPR
| Q4 25 | $-17.7M | — | ||
| Q3 25 | $-24.0M | $-31.3M | ||
| Q2 25 | $-24.7M | $-12.7M | ||
| Q1 25 | $-22.2M | $-40.5M | ||
| Q4 24 | $-32.6M | — | ||
| Q3 24 | $-16.9M | $-29.5M | ||
| Q2 24 | $-23.4M | $-61.9M | ||
| Q1 24 | $-21.5M | $61.0M |
毛利率AMPLESPR
| Q4 25 | 74.6% | — | ||
| Q3 25 | 73.9% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 74.7% | — | ||
| Q4 24 | 74.7% | — | ||
| Q3 24 | 75.1% | — | ||
| Q2 24 | 73.4% | — | ||
| Q1 24 | 74.0% | — |
营业利润率AMPLESPR
| Q4 25 | -18.3% | 50.6% | ||
| Q3 25 | -26.0% | -11.4% | ||
| Q2 25 | -29.0% | 8.6% | ||
| Q1 25 | -26.8% | -34.0% | ||
| Q4 24 | -41.2% | -6.4% | ||
| Q3 24 | -21.4% | -31.0% | ||
| Q2 24 | -31.7% | 3.5% | ||
| Q1 24 | -29.0% | 52.5% |
净利率AMPLESPR
| Q4 25 | -19.3% | — | ||
| Q3 25 | -27.1% | -35.9% | ||
| Q2 25 | -29.6% | -15.4% | ||
| Q1 25 | -27.8% | -62.2% | ||
| Q4 24 | -41.7% | — | ||
| Q3 24 | -22.4% | -57.2% | ||
| Q2 24 | -31.9% | -83.9% | ||
| Q1 24 | -29.5% | 44.3% |
每股收益（稀释后）AMPLESPR
| Q4 25 | $-0.13 | $0.32 | ||
| Q3 25 | $-0.18 | $-0.16 | ||
| Q2 25 | $-0.19 | $-0.06 | ||
| Q1 25 | $-0.17 | $-0.21 | ||
| Q4 24 | $-0.25 | $-0.14 | ||
| Q3 24 | $-0.14 | $-0.15 | ||
| Q2 24 | $-0.19 | $-0.33 | ||
| Q1 24 | $-0.18 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.0M | $167.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.3M | $-302.0M |
| 总资产 | $420.7M | $465.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMPLESPR
| Q4 25 | $192.0M | $167.9M | ||
| Q3 25 | $189.2M | $92.4M | ||
| Q2 25 | $208.1M | $86.1M | ||
| Q1 25 | $209.0M | $114.6M | ||
| Q4 24 | $241.1M | $144.8M | ||
| Q3 24 | $319.9M | $144.7M | ||
| Q2 24 | $318.3M | $189.3M | ||
| Q1 24 | $316.1M | $226.6M |
股东权益AMPLESPR
| Q4 25 | $245.3M | $-302.0M | ||
| Q3 25 | $262.2M | $-451.4M | ||
| Q2 25 | $279.5M | $-433.5M | ||
| Q1 25 | $289.5M | $-426.2M | ||
| Q4 24 | $296.6M | $-388.7M | ||
| Q3 24 | $290.0M | $-370.2M | ||
| Q2 24 | $287.3M | $-344.2M | ||
| Q1 24 | $289.2M | $-294.3M |
总资产AMPLESPR
| Q4 25 | $420.7M | $465.9M | ||
| Q3 25 | $438.1M | $364.0M | ||
| Q2 25 | $456.6M | $347.1M | ||
| Q1 25 | $445.8M | $324.0M | ||
| Q4 24 | $445.9M | $343.8M | ||
| Q3 24 | $445.6M | $314.1M | ||
| Q2 24 | $445.4M | $352.3M | ||
| Q1 24 | $437.9M | $373.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.8M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $12.7M | — |
| 自由现金流率自由现金流/营收 | 13.8% | — |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $28.2M | — |
8季度趋势，按日历期对齐
经营现金流AMPLESPR
| Q4 25 | $12.8M | $45.2M | ||
| Q3 25 | $5.0M | $-4.3M | ||
| Q2 25 | $20.1M | $-31.4M | ||
| Q1 25 | $-8.0M | $-22.6M | ||
| Q4 24 | $3.2M | $-35.0M | ||
| Q3 24 | $6.2M | $-35.3M | ||
| Q2 24 | $9.2M | $-7.2M | ||
| Q1 24 | $-48.0K | $53.8M |
自由现金流AMPLESPR
| Q4 25 | $12.7M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $19.5M | — | ||
| Q1 25 | $-8.5M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $6.2M | $-35.5M | ||
| Q2 24 | $8.6M | $-7.3M | ||
| Q1 24 | $-405.0K | $53.8M |
自由现金流率AMPLESPR
| Q4 25 | 13.8% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | -10.6% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 8.2% | -68.7% | ||
| Q2 24 | 11.8% | -9.9% | ||
| Q1 24 | -0.6% | 39.0% |
资本支出强度AMPLESPR
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.8% | 0.1% | ||
| Q1 24 | 0.5% | 0.1% |
现金转化率AMPLESPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPL
| US | $55.8M | 61% |
| International | $35.7M | 39% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
